Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)Depreciation ExpenseEBIATGross ProfitLeasesLong-Term Debt RepaymentsNon-Current ReceivablesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsPreferred Shares IssuedProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

INVO Fertility (IVF) Shares Outstanding (2016 - 2025)

INVO Fertility has reported Shares Outstanding over the past 16 years, most recently at $9475.0 for Q3 2025.

  • Quarterly Shares Outstanding fell 99.21% to $9475.0 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $9475.0 through Sep 2025, down 99.21% year-over-year, with the annual reading at $124345.0 for FY2024, 89.64% down from the prior year.
  • Shares Outstanding was $5.4 million for Q3 2025 at INVO Fertility, up from $10719.0 in the prior quarter.
  • Over five years, Shares Outstanding peaked at $12.1 million in Q1 2022 and troughed at $10719.0 in Q2 2025.
  • The 5-year median for Shares Outstanding is $608298.0 (2022), against an average of $3.0 million.
  • Year-over-year, Shares Outstanding soared 2266.02% in 2023 and then crashed 99.21% in 2025.
  • A 5-year view of Shares Outstanding shows it stood at $596457.0 in 2021, then plummeted by 91.5% to $50718.0 in 2022, then soared by 2266.02% to $1.2 million in 2023, then tumbled by 89.64% to $124345.0 in 2024, then plummeted by 92.38% to $9475.0 in 2025.
  • Per Business Quant, the three most recent readings for IVF's Shares Outstanding are $9475.0 (Q3 2025), $10719.0 (Q2 2025), and $248750.0 (Q1 2025).